APA

Canini L., Koh C., Cotler S. J., Uprichard S. L., Winters M. A., Han M. A. T., Kleiner D. E., Idilman R., Yurdaydin C., Glenn J. S., Heller T. & Dahari H. (062017). Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. : Hepatology communications.

Chicago

Canini Laetitia, Koh Christopher, Cotler Scott J, Uprichard Susan L, Winters Mark A, Han Ma Ai Thanda, Kleiner David E, Idilman Ramazan, Yurdaydin Cihan, Glenn Jeffrey S, Heller Theo and Dahari Harel. 062017. Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. : Hepatology communications.

Harvard

Canini L., Koh C., Cotler S. J., Uprichard S. L., Winters M. A., Han M. A. T., Kleiner D. E., Idilman R., Yurdaydin C., Glenn J. S., Heller T. and Dahari H. (062017). Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. : Hepatology communications.

MLA

Canini Laetitia, Koh Christopher, Cotler Scott J, Uprichard Susan L, Winters Mark A, Han Ma Ai Thanda, Kleiner David E, Idilman Ramazan, Yurdaydin Cihan, Glenn Jeffrey S, Heller Theo and Dahari Harel. Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. : Hepatology communications. 062017.